Acceleron Announces Proposed Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Nasdaq, S&P dip, trading choppy as tech stocks fall
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- UBS Reiterates Buy Rating on Snowflake Inc. (SNOW)
Acceleron Pharma (XLRN) Prices 3.75M Common Offering at $40/Share
January 6, 2016 6:19 AM ESTAcceleron Pharma Inc. (NASDAQ: XLRN) announced that it has priced an underwritten public offering of 3,750,000 shares of common stock at a price to the public of $40.00 per share for gross proceeds of $150 million. In connection with this offering, Acceleron has granted the underwriters a 30-day option to purchase up to an additional 562,500 shares of common stock.
Morgan Stanley, Leerink Partners LLC and UBS Investment Bank are acting as joint book-running managers for the offering. JMP Securities is acting as the lead manager and FBR is acting as co-manager for the... More
Acceleron Pharma (XLRN) Files $300M Common Stock Shelf
January 5, 2016 7:17 AM ESTAcceleron Pharma (NASDAQ: XLRN) filed a registration with the U.S. SEC to sell up to $300 million worth of its common stock.
... More